EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Small-molecule agents for cancer immunotherapy

Fang Wang, Kai Fu, Yujue Wang, Can Pan, Xueping Wang, Zeyu Liu, Chuan Yang, Ying Zheng, Xiaopeng Li, Yu Lu, Kenneth Kin Wah To, Chenglai Xia und 5 weitere

Acta Pharmaceutica Sinica B · 2024-03 · 14 (3) · 905-952

DOI: 10.1016/j.apsb.2023.12.010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2024-03. Verfasst von Fang Wang und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangdon…. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 278 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Guangzhou Municipal Science and Technology Program key projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Antitumor immunityCancer immunotherapyCytokine/chemokine signalingImmune checkpointsMetabolic pathwaysOncogenic signalingSmall-molecule agentsTumor immune microenvironment

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen Universi…
  • School of Pharmaceutical Sciences, Tsinghua-Peking Center for Life Sciences, Beijing Frontier Research Center for Biological Structure, Tsinghua University, Beijing 100084, China.
  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Department of Cell Biology & Institute of Biomedicine, National Engineering Research Center of Genetic Medicine, MOE Key Laboratory of Tumor Molecular Biology, Guangdong Provincial Key Laboratory of Bioengineering Medic…
  • Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated H…
  • School of Pharmacy, The Chinese University of Hong Kong, Hong Kong 999077, China.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Guangzhou Municipal Science and Technology Program key projects

Zitieren

APA

Wang, F., Fu, K., Wang, Y., Pan, C., Wang, X., Liu, Z., Yang, C., Zheng, Y., Li, X., Lu, Y., To, K. K. W., Xia, C., Zhang, J., Shi, Z., Hu, Z., Huang, M., & Fu, L. (2024). Small-molecule agents for cancer immunotherapy. Acta Pharmaceutica Sinica B, 14(3), 905-952. https://doi.org/10.1016/j.apsb.2023.12.010

Vancouver

Wang F, Fu K, Wang Y, Pan C, Wang X, Liu Z, et al. Small-molecule agents for cancer immunotherapy. Acta Pharmaceutica Sinica B. 2024;14(3):905-952. doi:10.1016/j.apsb.2023.12.010

BibTeX
@article{Wang2024,
  author = {Wang, Fang and Fu, Kai and Wang, Yujue and Pan, Can and Wang, Xueping and Liu, Zeyu and Yang, Chuan and Zheng, Ying and Li, Xiaopeng and Lu, Yu and To, Kenneth Kin Wah and Xia, Chenglai and Zhang, Jianye and Shi, Zhi and Hu, Zeping and Huang, Min and Fu, Liwu},
  title = {Small-molecule agents for cancer immunotherapy},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2024},
  volume = {14},
  number = {3},
  pages = {905--952},
  doi = {10.1016/j.apsb.2023.12.010}
}
Kostenlos starten →